Athenex Provides an Update on Oral Paclitaxel FDA Meeting

NEXT STORY
Aravive Announces Board Composition and Executive Management Transitions
PREV STORY
Outlook on the Worldwide Precision Medicine Industry to 2025 – Growing Focus on Biomarkers is Promising Ample Opportunities
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

President Obama to Address Fifth Annual National Rx Drug Abuse & Heroin Summit; Appriss to Sponsor and Host Speaking Session

LOUISVILLE, K.Y., March 24, 2016 (GLOBE NEWSWIRE) -- Appriss, Inc., will sponsor the 2016 ...

author_avatar
NASDAQ Market News

Primary analysis results from Novartis pivotal JULIET trial show Kymriah(TM) (tisagenlecleucel) sustained complete responses at six months in adults with r/r DLBCL, a difficult-to-treat cancer

At six months, 30% of patients treated with Kymriah were in complete response, with ...

author_avatar
NASDAQ Market News

MacroGenics Announces Date of Second Quarter 2017 Financial Results Conference Call

ROCKVILLE, MD, July 26, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX) today announced ...

author_avatar
NASDAQ Market News